{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:51:59Z","timestamp":1794959519650,"version":"4.9.1"},"reference-count":34,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T00:00:00Z","timestamp":1515628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>To determine the incidence of drug\u2010related deaths (DRD) in a university hospital in 2015, to describe their characteristics, and to discover risk factors of DRD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>An analytic and retrospective cohort study. Patients with a death diagnosed predefined from a list of medical conditions potentially caused by drugs were the selected cases for further review. Causality assessment was evaluated by a local drug safety committee.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Out of 1135 inpatient deaths, 73 DRD were included (six were hospital\u2010acquired). The incidence of DRD of all hospital admissions was 0.34%, and the incidence of all deaths cases was 7%. Drugs were the cause of death in 38 patients (52%) and a contributive role in 35 (48%). The median age of DRD patients was 72\u00a0years (range 19\u201394) and 72.6% were men. The median hospital stay, Charlson score and number of drugs were 5\u00a0days, 2 points and seven drugs respectively. The most frequent DRD were cerebral haemorrhages and infections in drug\u2010immunosuppressed patients (32, 43.8%, each group). The most frequently involved drugs were antineoplastics and glucocorticosteroids (40% and 18%), and antithrombotics (33%); drug\u2013drug interactions were present in 44% DRD. Sex, age and number of drugs were risk factors of DRD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Adverse drug reactions were a significant cause of death in hospitalized patients, mainly haemorrhages and infections precipitated by drug\u2013drug interactions. Risk factors for DRD were sex, age and number of drugs. Preventable DRD and measures to avoid them should be accurately assessed in further studies.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bcp.13471","type":"journal-article","created":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T07:32:39Z","timestamp":1510903959000},"page":"542-552","source":"Crossref","is-referenced-by-count":52,"title":["Drug\u2010related deaths in hospital inpatients: A retrospective cohort study"],"prefix":"10.1111","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1691-7652","authenticated-orcid":false,"given":"Eva","family":"Montan\u00e9","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology Hospital Universitari Germans Trias i Pujol  Badalona Barcelona Spain"},{"name":"Department of Pharmacology, Therapeutics and Toxicology Universitat Aut\u00f2noma de Barcelona  Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Luc\u00eda","family":"Arellano","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology Hospital Universitari Germans Trias i Pujol  Badalona Barcelona Spain"},{"name":"Department of Pharmacology, Therapeutics and Toxicology Universitat Aut\u00f2noma de Barcelona  Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Sanz","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology Hospital Universitari Germans Trias i Pujol  Badalona Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Roca","sequence":"additional","affiliation":[{"name":"Epidemiology Unit Hospital Universitari Germans Trias i Pujol  Badalona Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8338-7543","authenticated-orcid":false,"given":"Mag\u00ed","family":"Farr\u00e9","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology Hospital Universitari Germans Trias i Pujol  Badalona Barcelona Spain"},{"name":"Department of Pharmacology, Therapeutics and Toxicology Universitat Aut\u00f2noma de Barcelona  Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,1,11]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P627"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7140.1295"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.4.483"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.15.1200"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1L037"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.5414\/CPP47596"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-016-2026-0"},{"key":"e_1_2_9_9_1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/bcpt.12435","article-title":"Drug\u2010related inadvertent deaths in a university hospital \u2013 a declining trend","volume":"117","author":"Lapatto\u2010Reinilouto O","year":"2015","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-002-0501-2"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040297"},{"key":"e_1_2_9_12_1","unstructured":"Commission directive 2010\/84\/EU of the European Parliament and the council of 15 December 2010 amending as regards pharmacovigilance directive 2001\/83\/EC on the community code relating to medicinal products for human use. Official Journal of the European Union 31.12.2010: L348\/74\u2010L348\/99. Available athttp:\/\/ec.europa.eu\/health\/files\/eudralex\/vol\u20101\/dir_2010_84\/dir_2010_84_en.pdf(last accessed 23 September 2017)."},{"key":"e_1_2_9_13_1","first-page":"538","article-title":"Focusing on the preventability of adverse drug reactions","volume":"27","author":"Schumock GT","year":"1992","journal-title":"Hosp Pharm"},{"key":"e_1_2_9_14_1","volume-title":"The use of the WHO\u2010UMC system for standardized case causality assessment","author":"World Health Organization"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1037"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13882"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-015-0281-0"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02799-9"},{"key":"e_1_2_9_21_1","unstructured":"World health organization technical report series (1972 no 498). International Drug Monitoring. The Role of the National Centres. Report of a WHO Meeting. Geneva Switzerland. Available athttp:\/\/apps.who.int\/iris\/bitstream\/10665\/40968\/1\/WHO_TRS_498.pdf(last accessed 23 September 2017)."},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12567"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.19.2317"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/psp.2012.8"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2001.00892.x"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.03064.x"},{"key":"e_1_2_9_27_1","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/jama.1977.03270360041015","article-title":"Drug\u2010related deaths among medical inpatients","volume":"237","author":"Porter J","year":"1977","journal-title":"JAMA"},{"key":"e_1_2_9_28_1","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/archinte.1976.03630080014006","article-title":"Drug\u2010associated deaths of medical inpatients","volume":"136","author":"Caranasos GJ","year":"1976","journal-title":"Arch Intern Med"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091217415621269"},{"key":"e_1_2_9_30_1","first-page":"18","volume-title":"Textbook of adverse drug reactions","author":"Rawlins MD","year":"1991"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.2165\/11534400-000000000-00000"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.48"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.5414\/CP201514"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0b013e3181f44abc"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-013-1630-5"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbcp.13471","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.13471","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T16:25:01Z","timestamp":1695745501000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.13471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,11]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["10.1111\/bcp.13471"],"URL":"https:\/\/doi.org\/10.1111\/bcp.13471","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,11]]}}}